General
Preferred name
Transcrocetinate
Synonyms
Disodium trans-crocetinate ()
Crocetin (disodium) ()
Crocetin (meglumine) ()
CROCETIN ()
Transcrocetinate disodium ()
Transcrocetin (disodium) ()
trans-Crocetin (disodium) ()
Transcrocetin (meglumine) ()
trans-Crocetin (meglumine) ()
Trans sodium crocetinate, Transcrocetinate disodium ()
Transcrocetin ()
trans-Crocetin ()
Transcrocetine ()
Leaf-4l7520 ()
Ci 75100 ()
8,8-diapocarotenedioic acid ()
LEAF-4L6715 ()
Transcrocetin component of leaf-4l6715 ate ()
Transcrocetina ()
Transcrocetinic acid ()
CI-75100 ()
NSC-407300 ()
TSC ()
Trans sodium crocetinate ()
TRANSCROCETINATE SODIUM ()
P&D ID
PD077077
CAS
591230-99-8
27876-94-4
Tags
available
drug candidate
Drug Status
investigational
Max Phase
3.0
Drug indication
COVID-19
Glioblastoma multiforme
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Crocetin (Transcrocetin) meglumine, extracted from saffron (Crocus sativus L.), acts as an NMDA receptor antagonist with high affinity.
PRICE 105
DESCRIPTION Transcrocetinate disodium (Disodium trans-crocetinate), extracted from saffron (Crocus sativus L.), is a high-affinity antagonist of NMDA receptor. (TargetMol Bioactive Compound Library)
Cell lines
1
Organisms
0
Compound Sets
7
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugBank
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
58
Properties
(calculated by RDKit )
Molecular Weight
328.17
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
8
Ring Count
0
Aromatic Ring Count
0
cLogP
4.61
TPSA
74.6
Fraction CSP3
0.2
Chiral centers
0.0
Largest ring
0.0
QED
0.5
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Membrane Transporter/Ion Channel
Neuroscience
Neuronal Signaling
Immunology/Inflammation
MAPK/ERK Pathway
MOA
glutamate receptor antagonist
Target
Apoptosis
COX
iGluR
p38 MAPK
NMDAR
NMDAR, Antioxidant
NMDA Receptor
Source data